vancomycin has been researched along with interleukin-8 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dower, SK; Moore, LJ; Pridmore, AC; Read, RC | 1 |
Agusti, C; de la Bellacasa, JP; Esperatti, M; Filella, X; Guerrero, L; Li Bassi, G; Liapikou, M; Luque, N; Marco, F; Martinez-Olondris, P; Quera, MA; Rigol, M; Soy, D; Torres, A | 1 |
Afasizheva, A; Badiou, C; Chambers, HF; Diep, BA; Kajikawa, O; Le, HN; Lina, G; Matute-Bello, G; Sellman, B; Tkaczyk, C | 1 |
Beamer, G; Kim, HB; Sun, X; Tzipori, S; Wang, Y; Zhang, Q | 1 |
Alam, MJ; Bassères, E; Chesnel, L; Endres, BT; Garey, KW; Khaleduzzaman, M | 1 |
Bryers, JD; Katzenmeyer, KN; Szott, LM | 1 |
Baba, T; Inoue, Y; Matsuura, K; Miyake, H; Miyazaki, D; Sasaki, SI; Shimizu, Y | 1 |
7 other study(ies) available for vancomycin and interleukin-8
Article | Year |
---|---|
The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cell Wall; Cephalosporins; Genes, Reporter; HeLa Cells; Humans; Interleukin-8; Lactams; Lipopolysaccharide Receptors; Luciferases; Membrane Glycoproteins; Microbial Sensitivity Tests; Plasmids; Receptors, Cell Surface; Streptococcus pneumoniae; Toll-Like Receptor 2; Toll-Like Receptors; Transfection; Vancomycin | 2004 |
Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Interleukin-6; Interleukin-8; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Respiration, Artificial; Swine; Tumor Necrosis Factor-alpha; Vancomycin | 2012 |
Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Toxins; Chemokine CCL2; Disease Models, Animal; Exotoxins; Hemolysin Proteins; Interleukin-8; Leukocidins; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Rabbits; Vancomycin | 2013 |
Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Fluoroquinolones; Germ-Free Life; Humans; Interleukin-8; Microbiota; Minocycline; Pyrimidinones; Swine; Tigecycline; Vancomycin | 2014 |
Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Caco-2 Cells; Cell Line, Tumor; Clostridioides difficile; Enterotoxins; Humans; Interleukin-8; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peptides, Cyclic; Vancomycin | 2016 |
Artificial opsonin enhances bacterial phagocytosis, oxidative burst and chemokine production by human neutrophils.
Topics: Humans; Immunity, Innate; Immunoconjugates; Immunoglobulin Fc Fragments; Immunoglobulin G; Interleukin-8; Neutrophils; Opsonin Proteins; Phagocytosis; Polyethylene Glycols; Polylysine; Primary Cell Culture; Reactive Oxygen Species; Respiratory Burst; Staphylococcus epidermidis; Vancomycin | 2017 |
Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Cell Survival; Cells, Cultured; Endothelial Cells; Esterases; Humans; Interleukin-8; Intravitreal Injections; Mice; Moxifloxacin; Pericytes; Retina; Vancomycin | 2019 |